Results 101 to 110 of about 60,579 (288)

Presenting Clinical Features of Vitreoretinal Lymphoma

open access: yesClinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background Vitreoretinal lymphoma is a rare cancer, widely recognised to present diagnostic challenges. We aimed to report information that would support the clinician in considering this diagnosis. Methods We interrogated the International Vitreoretinal B‐Cell Lymphoma Registry for clinical data from patients newly diagnosed with ...
The International Vitreoretinal B‐Cell Lymphoma Registry Investigator Group   +64 more
wiley   +1 more source

Clinical Observation of Allergic Conjunctival Diseases with Portable and Recordable Slit-Lamp Device. [PDF]

open access: yesDiagnostics (Basel), 2021
Yazu H   +10 more
europepmc   +1 more source

Duration‐Dependent Efficacy and Clinical Safety of Repeated Low‐Level Red‐Light Therapy for Paediatric Myopia: A Systematic Review and Meta‐Analysis

open access: yesClinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background Repeated low‐level red‐light (RLRL) therapy is a novel, non‐invasive intervention for controlling paediatric myopia progression. Despite increasing clinical use, questions remain regarding the magnitude, durability, and safety of treatment effects.
Lee‐Yuan Lin   +8 more
wiley   +1 more source

Long-term outcomes of 0.1% tacrolimus eye drops in eyes with severe allergic conjunctival diseases. [PDF]

open access: yesAllergy Asthma Clin Immunol, 2021
Yazu H   +4 more
europepmc   +1 more source

Prevalence, Treatment, and Outcomes of Corneal Disease in Aboriginal and Torres Strait Islander Peoples in Australia: A Systematic Review

open access: yesClinical &Experimental Ophthalmology, EarlyView.
ABSTRACT Background To synthesise available evidence on the prevalence, treatment strategies, and outcomes of corneal disease affecting Aboriginal and Torres Strait Islander peoples in Australia, and to identify gaps in the existing literature. Methods A systematic review with narrative synthesis was conducted in accordance with PRISMA 2020 guidelines.
Angus van der Nagel   +3 more
wiley   +1 more source

Conjunctival capillary hemangioma - A rare case

open access: yesKerala Journal of Ophthalmology
Conjunctival capillary hemangioma is very rare, with few cases being reported in the literature. We present a case of a 60-year-old male with conjunctival capillary hemangioma, a unique case adding to the literature of uncommon vascular tumor.
Anusha Aynala   +2 more
doaj   +1 more source

SmartHeLP: Smartphone-based Hemoglobin Level Prediction Using an Artificial Neural Network [PDF]

open access: yes, 2018
Blood hemoglobin level (Hgb) measurement has a vital role in the diagnosis, evaluation, and management of numerous diseases. We describe the use of smartphone video imaging and an artificial neural network (ANN) system to estimate Hgb levels non ...
Adib, Riddhiman   +7 more
core   +1 more source

Monitoring wildlife health for diseases with visible signs by integrating camera traps with marked individuals

open access: yesConservation Biology, EarlyView.
Abstract Monitoring wildlife health is essential for conservation and management, wildlife and livestock welfare, and public health in a One Health framework. Yet, wildlife health monitoring often requires long‐term fieldwork and intensive sampling, which can be costly or logistically challenging, especially for remote, rare, or elusive populations. To
Jonathan Tichon   +8 more
wiley   +1 more source

ITGA5 as a Dual Regulator of Epithelial‐Mesenchymal Transition and Epithelial Cell Anoikis Resistance: Functional Validation and Drug Prediction

open access: yesCell Proliferation, EarlyView.
Proteomics and functional validation reveal ITGA5 as a dual promoter of epithelial‐mesenchymal transition and anoikis resistance in human bronchial epithelium: targeting ITGA5 represents a novel therapeutic strategy for asthma airway remodelling. ABSTRACT Airway remodelling is a major contributor to persistent airflow limitation and irreversible lung ...
Ting Wang   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy